Search results for: 'fa02 retardants development'

19 Sep 2018  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

Infographics

×

Key Issues Addressed

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

The study analyses the Kenyan and Rwandan health care landscape, market outlook, and investment and growth opportunities. It also discusses the drivers and restraints and the dynamics of the hospital construction market and concludes by providing a list of upcoming projects and strategic recommendations for the markets in Kenya and Rwanda. The res...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

Blockchain is finally overcoming early confusion and hype. It is a spectrum technology that can be applied to achieve many possible outcomes. Its best uses are in the creation of trusted digital connective tissue in open, complex ecosystems and in the programmatic creation of digital value where it cannot be easily be replaced by centralized system...

People flow solutions (PFS) is a term newly introduced in the building systems industry. It generally defines the technologies or solutions applied for people flow control and management in and outside of a building. PFS has an increasingly significant role to play in conjunction with the rapid urbanization, where human and road traffic are getting...

The Mobility Technology Opportunity Engine (TOE) covers innovations pertaining to EV Charging, V2X Platforms, LiDAR, and Autonomous Vehicle Development among others.The purpose of the Mobility Technology TOE is to raise awareness of global technology innovations in self-propelled ground-based mobile platforms that are not only technically significa...

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...